St. Johns Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

St. Johns Investment Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4	Closed	-$115	–	209
2024 Q1	$115	Hold	4	–	–	﹤0.01%	214
2023 Q4	$131	Hold	4	–	–	﹤0.01%	190
2023 Q3	$111	Hold	4	–	–	﹤0.01%	192
2023 Q2	$136	Hold	4	–	–	﹤0.01%	196
2023 Q1	$120	Hold	4	–	–	﹤0.01%	177
2022 Q4	$113	Hold	4	–	–	﹤0.01%	174
2022 Q3	$0	Hold	4	–	–	﹤0.01%	170
2022 Q2	$0	Hold	4	–	–	﹤0.01%	168
2022 Q1	$0	Hold	4	–	–	﹤0.01%	180
2021 Q4	$0	Hold	4	–	–	﹤0.01%	189
2021 Q3	$0	Hold	4	–	–	﹤0.01%	176
2021 Q2	$0	Hold	4	–	–	﹤0.01%	200
2021 Q1	$0	Buy	+4	New	+$397	﹤0.01%	169

Other funds holding ARKG

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

St. Johns Investment Management's ARKG Position: Q2 2024 in Review

St. Johns Investment Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 4 shares — an estimated $115 sold.

St. Johns Investment Management first reported a position in ARKG in Q1 2021 and held it in 13 quarters. The position peaked at $136 in Q2 2023. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

St. Johns Investment Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
St. Johns Investment Management sold 4 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $115.
St. Johns Investment Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 13 quarters.
St. Johns Investment Management's ARK Genomic Revolution ETF position peaked at $136 in Q2 2023.
261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on St. Johns Investment Management's 13F filing for Q2 2024, filed 25 Jul 2024.